Edition:
India

Advaxis Inc (ADXS.OQ)

ADXS.OQ on NASDAQ Stock Exchange Global Select Market

2.98USD
17 Jan 2018
Change (% chg)

$0.06 (+2.05%)
Prev Close
$2.92
Open
$2.96
Day's High
$2.99
Day's Low
$2.86
Volume
155,766
Avg. Vol
208,894
52-wk High
$10.05
52-wk Low
$2.71

Latest Key Developments (Source: Significant Developments)

Aratana Therapeutics Granted Conditional License For A Canine Osteosarcoma Therapeutic
Wednesday, 20 Dec 2017 

Dec 20 (Reuters) - Advaxis Inc ::ARATANA THERAPEUTICS GRANTED CONDITIONAL LICENSE FOR A CANINE OSTEOSARCOMA THERAPEUTIC.ARATANA THERAPEUTICS-U.S. DEPARTMENT OF AGRICULTURE CENTER FOR VETERINARY BIOLOGICS GRANTED CONDITIONAL LICENSE​ FOR CANINE OSTEOSARCOMA VACCINE,AT-014.  Full Article

Amgen reports 8.9 pct passive stake in Advaxis as of Aug 1
Tuesday, 2 Aug 2016 

Amgen Inc Reports 8.9 Pct Passive Stake In Advaxis Inc As Of August 1 :Sec filing.  Full Article

Advaxis files for common stock offering
Tuesday, 2 Aug 2016 

Advaxis Inc :Files for common stock offering of up to 3.05 million shares - SEC filing.  Full Article

Advaxis Inc says FDA grants advaxis fast track designation for ADXS-HER2
Thursday, 28 Apr 2016 

Advaxis Inc:Says FDA has granted fast track designation for company's immunotherapy product candidate ADXS-HER2 for patients with newly-diagnosed, non-metastatic, surgically-resectable osteosarcoma.  Full Article